chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My menstrual cycles have always been very regular.  The only time I have ever missed a period was with my 2 pregnancies in the past.   Everything started in April which was the month after my second Moderna dose.  My period was almost 2 weeks late(11 or 12 days).  I took half a dozen pregnancy tests over that time period and they were all negative.  When I did finally get my period I bled so much for so long.  It was very heavy(scary heavy) for about a week and a half and then switched to a normal period flow but I bled for about 3 weeks total.  After 11 or 12 days of bleeding I called and saw the Nurse practitioner at my OB/Gyn office.  At that appointment she did an endometrial biopsy but didn?t prescribe anything for the bleeding bc my hemoglobin was still within normal limits and we were just going to try and wait for the biopsy results to come back to make sure the sample was adequate.  Also, while we were waiting for the biopsy to come back, I went for a transabdominal and transvaginal ultrasound to get a better idea of what was going on.  By the time we got the results of everything back a couple weeks had gone by and it had stopped or almost stopped. 2 weeks of no bleeding and then it started again.  It wasn?t very heavy like the month before but after maybe 9 days of bleeding I called the office back and said i needed them to look into it further bc something was definitely wrong.  They scheduled me for a consult with my primary OB/Gyn 4 weeks later since the office was very busy.  On day 19 of bleeding I finally just called my doctor and discussed everything over the phone.  He pretty much said we can skip the consult appointment and just call the office in the morning and they?ll schedule me for a hysteroscopy, which they did.  My hysteroscopy was scheduled for August 10th(today).  During the second round of bleeding I bled for over 7 weeks straight.  I was prescribed oral progesterone which did not help initially but was increased and finally brought the bleeding to an end about 2 weeks ago.  I have essentially been bleeding since May 3rd and the hysteroscopy today showed no indication of why I continued to bleed like that.  There were no polyps  and no fibroids discovered.  Now I am stuck getting an IUD placed to attempt to control this bleeding and my chances of expanding my family become smaller and smaller every single day.
The following day (03/27/2021) my daughter started experiencing chills, fatigue, and congestion. On 03/28/2021 at 06:00 am my daughter stated feeling pressure to her chest on and off throughout the day. At 10:00 pm she was taken to the Emergency Room. She was transferred due to having abnormal results in EKG performed. She was admitted and discharged on 03/29/2021 with dx Pericarditis, prescribed Ibuprofen 800mg 1 tablet by mouth 3 times a day x 10 days and Metoprol Suc  25 mg ER 1 tablet by  mouth once a day .
I developed vaginal bleeding that resulted  in a prescription of vaginal estrogen cream. Because I had already had a hysteroscopy and D&C done on 03/03/2021 from the reaction of the first dose. The bleeding lasted 3 days and stopped on it's own. I had a known fibroid on the uterus.
Patient was administered 0.3 mL monovalent Pfizer instead of intended 0.3 mL bivalent Pfizer due to medication administration error. Pfizer monovalent/bivalent vials look similar and have the same-colored caps which led to the pharmacist drawing up the wrong dose. Patient was informed of the error within a few days and provided medical advice. No adverse reactions reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 at 09:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 48 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Rebound and tested positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness, edema and tenderness within 2-3cm surrounding injection site. No evidence of superficial infection.
Felt flush, faint immediately after vaccination, sent to ER - was checked out and released - no admit. Reported improvement prior to leaving.
Only extremities and chest was affected with psoriasis. From waist down to knees was clear, Fingertips to t-shirt sleeve area, neck, chest, ect. I got worried when other notice my sores and I went my PA, a dermatologist. The first test was with a new dermatologist, biopsy came back negative. Gave me Triamcinolone to treat. Also, tried Clobetasol, Ultravate, Otezla, ect. After it got worse she did a punch needle test and came back dermatitis. Checked with another for second opinion, Dr. and was given a blood test who later found it was also psoriasis. First tried D3 50,000IU and B. Started taking other OTC and my Psoriasis is a lot better but tends to pop up here and there ever so often and no where near severe as it has been.
I have developed a rash on my neck and chest that seems to be spreading . I also was pretty sick following the vaccine but most of that has resolved. The rash has not.
I developed symptoms for Covid-19 on 01/18/2022. I had chills, a low grade fever at 102, and body aches. I received anti-viral pills as treatment. On 01/22/22, I also received an infusion treatment. I still have a lingering cough and there is a popping sensation in my right ear.
Age: 79 y.o. Admit Date: 7/17/2022  7:54 PM Discharge Date: 7/19/2022  Unit: 3A131/3A131A   Discharge Diagnosis: Principal Problem:   COVID-19 Active Problems:   CAD (coronary artery disease)   CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min   NSTEMI (non-ST elevated myocardial infarction)       HPI AND HOSPITAL COURSE   History of Present Illness:  As per admission H&P, "Patient is a 79 y.o. male with a history of ASHD. Short of breath a week brought on by COVID infection. Has been on paxlovid and not better. Worse with exertion. To ED with shortness of breath and "hurts all over". Fever still and coughing. Some nausea and diarrhea. "       Hospital Course: Patient, is a 79 y.o. male who presented with SOA.   He was managed for the following:   * COVID-19 COVID-19 infection - Found to be covid positive.  He was treated with remdesivir.  He was stable  on room air, no indication for steroids.  he felt improved, discharge home in stable condition.    Elevated d-dimer - BLE US negative for DVT.  CT PE study negative for PE.    Elevated troponin - to 0.14. Type 2 MI Cardiology was consulted.  LHC showed patent stents, small OM branch with 70% stenosis.  No new stents placed.  Imdur was added per cardiology.  F/u outpatient.                Physical Exam on the Date of Discharge: Blood pressure 137/58, pulse 84, temperature 98 °F (36.7 °C), temperature source Oral, resp. rate 18, height 5' 5" (165.1 cm), weight 85.5 kg (188 lb 6.4 oz), SpO2 98 %. General - NAD, appears stated age  HEENT - EOMI, PER, MMM, oropharynx clear Chest - lungs clear bilaterally, no w/r/r, normal effort Heart - RRR, NS1S2, no m/r/g Abdomen - Soft, non-tender, non-distended, +BS,  Extremities - warm, no edema Psych - AAOx3, affect appropriate Skin - no rash, dry   Discharge Condition: improved   Disposition: home
feels like a blood clot; My right calf has felt strange ever since the second dose and it feels like a blood clot/toes also felt strange/My toes also felt strange for a few weeks but that subsided; a tightness in the leg that doesn't want to go away; This is a spontaneous report received from a contactable consumer. This consumer reported for himself that the 35-year-old male patient received second dose of bnt162b2 (BNT162B2, Pfizer COVID 19), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:00 (Batch/Lot Number: 6203) as 2nd dose, single for covid-19 immunisation.  Medical history was none. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, Pfizer COVID 19, Lot number=9265) on 01Feb2021,01:00 PM,in Left arm for covid-19 immunisation. The patient experienced feels like a blood clot on 23Feb2021 with outcome of not recovered , my right calf has felt strange ever since the second dose and it feels like a blood clot/toes also felt strange/my toes also felt strange for a few weeks but that subsided on 23Feb2021 with outcome of not recovered , a tightness in the leg that doesn't want to go away on 23Feb2021 with outcome of not recovered. No treatment received for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No List of any other medications the patient received within 2 weeks of vaccination.   The clinical course was reported as follows: My right calf has felt strange ever since the second dose and it feels like a blood clot. There is a tightness in the leg that doesn't want to go away. My toes also felt strange for a few weeks but that subsided. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No Known allergies.   Follow up letter has been generated for further information.
Other than typical sore arm at injection site, I began to experience massive body tremors and painful chills that started roughly 13 hours after second Moderna dose. The chills were so extreme that my abdomen tightened and caused pain that I could not relax along with jaw tightening and teeth chatter. Once in bed, I experienced severe sweating while trying to stop the chills, then massive chills when removing blankets and extreme all over body aches that caused me to toss and turn all night. I found myself fatigued and sleeping off and on until 5:30 pm (17 hours in bed) the next evening. Chills have since subsided, body aches remained- tiredness remained. Two Tylenol have mostly helped with the body aches, although they are definitely still present, even in my gut.
Patient received Pfizer Covid-19 >12yo  dose instead of pediatric (5-11yo) dose
Received tetanus injection to left deltoid within 12 hours became red, warmth at site, itching with increase in signs and symptoms with treatment with Prednisone and Keflex for 10 days.
Case number PHEH2013US023750 is an initial spontaneous report received from a pharmacist on 12 NOV 2013. This report refers to a patient of unknown age and gender. On 12 NOV 2013, the patient ws vaccinated with FLUVIRIN 2013-2014 (batch number: 1309201) intradermally, instead of PPD (other manufacturer, batch number unknown). No adverse reaction was reported following this administration error (wrong vaccine administered).
migraine; This case was reported by a nurse via sales rep and described the occurrence of migraine in a 16-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, 1 day after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced migraine. On an unknown date, the outcome of the migraine was unknown.   It was unknown if the reporter considered the migraine to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The nurse reported that the patient experienced a migraine the day after first Bexsero injection. No further information reported. The reporter did not consent to follow up.
Inbound call from nurse to complete temperature excursion for VARIVAX. Complete excursion details collected from nurse, it was reported that the vaccine was administered after temperature excursion. No PQC. No additional information.         ?    N; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 29-APR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U026207, expiration date 24-AUG-2023 and lot number U029496, expiration date 21-SEP-2023) as prophylaxis, after temperature excursion (product storage error).  The vaccines experienced a temperature excursion of minus (-) 9 degrees Celsius (C) for 1 hour and 45 minutes. There was no previous temperature excursion.
Diarrhea. Extremely rancid, thick, pulpy, brownish poop. Abnormal as baby is breastfed and usually has liquidy lighter-colored poop.
Swollen lymph node/under arm on the left side; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175), via an unspecified route of administration in the left arm on 28Apr2021 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history included herpes simplex type II. Concomitant medications included ibuprofen sodium (IBUPROFEN) from unknown date for an unknown indication and valaciclovir hydrochloride (VALTREX) from unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced swollen lymph node/ under arm on the left side. The clinical outcome of the event swollen lymph node/under arm on the left side was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Pt recv vax on 2/24/99; on 2/25/99 pt exp swollen LA, not moving LA; tx=antibiotics & warm compresses
Headache, abdominal discomfort, general ill feeling. BP 124/90, P-92. Did not feel well enough to remain at school and was picked up by parent.  Returned to school on 12/8/09.
Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge; No adverse event; Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005c21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 31-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge) and PRODUCT STORAGE ERROR (Patient received the moderna monovalent vaccines (1st & 2nd doses) after being more than 30 days stored in the fridge).    Concomitant product use was not provider by the reporter.  The vaccines were stored in the fridge on 30-Jun-2021. Best used date was reported as 30-Jul-2021. Doses were administered between 02-Aug-2021 and 20-Sep-2021. Patient did not report any side effects.  Treatment information was not provided.
pt recvd vax;welt noted at inject site; was large & itchy;raised welt like rash but not reddened; had spread down arms, chest, back, torso, up neck, buttocks;
red and swollen right thigh diagnosis-cellulitis antibiotic-Cephalexin 125 mg
Pt experienced pain in his left deltoid after the HPV9 vaccine was given. He has been experiencing a sharp pain in that site whenever he raises his arm and it has persisted for over 2 weeks. He had an x ray of his arm which was negative.
On 1/13/2021, I received my first dose of the Moderna vaccine. On1/23/2021, I developed a rash at the injection site, which went away within 10 days. On 2/13/2021, I received the second dose. On about 2/20/2021, I developed a rash over various parts of my body. They look like spider bites and are pimple-like bumps filled with clear liquid. It looked like acne, but the bumps had no pus. The bumps would pop up from nowhere in random places. Every part of my body has been affected at some point, save for the palms of my hands, the soles of my feet, and my genital area. My face has mostly been unaffected, though I have had a few bumps on my nose. I went to my PCP, and I was referred to a dermatologist. The dermatologist gave me steroidal cream. The bumps would disappear after a few days when I put the cream on them. To this day, I still have bumps that pop up, and I treat them with the cream the dermatologist gave me.
Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy and concurrent condition were not provided. On an unknown date, the patient was vaccinated with improperly stored VARIVAX (strength, dose and frequency were unknown; lot # was L048468 with expiration date 02-DEC-2017). No adverse effects were reported. This is one of several reports that received from the same reporter. Additional information has been requested.
17MAR95 pain @ inj site-gen malaise x 24hrs; 20MAR95 pain @ inj site; 24MAR95 gen malaise, fever pain @ inj site; labile emotions-lots of crying;
red, raised, feverish area around injection site approxiamately 8cm in diameter.
She had mild migraines lasting a couple of days for the last year and a half. The next day after She received the vaccine she started a severe migaine headache that has not stopped for more than a couple of times for two days, one time after being hospitalized and receiving solumedral and DHE. Went to the ER three times to try to relieve the headache. On preventative medication for her daily headache but it has not helped yet. Has been out of school since 4/18.
SAhortly after taking the shot, I have had non stop static buzzing noise in both my ears that does not go away. After several weeks the volume of the static buzzing noise increased. I went to my primary doctor and then an ENT (ear specialist) and was diagnosed with Tinnitus. Previously before the vaccine I was completely healthy and had no history of any ear related medical issues.   I also have been having heart pain on my chest. It is due to my heart valve being inflamed.  Anti inflamatory were prescribed but did not help much. I am scheduled to see a cardiologist.
Information has been received from a registered nurse concerning a 65 year old female, who on 10/24/05 at 11:30 was vaccinated into the left deltoid with a first dose of Pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). There was no illness at the time of vaccination. ON 10/24/05, the pt developed itching and half moon sized redness. By the evening, the pt experienced pain at the site. On 10/25/05, the pts pain was radiating into her left breast, and she complained of swelling and pain in her entire upper left arm down to her left elbow. She also experienced a fever of 101 deg F and said that she felt bad. the pt was going to use ice packs and Ibuprofen Advil. The pts was advised to call the office if there was no improvement. At the time of this report, the pts outcome was unknown. Additional information has been requested.
This spontaneous report was received from a certified medical assistant and refers to a 12-month-old female patient. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided. On 03-AUG-2022, the patient was vaccinated with M-M-R II injection, 0.5 ml, once, lot # T025930 confirmed to be valid with expiration date: 30-JUL-2022 (route of administration and anatomical location were not reported) for prophylaxis (expired product administered). The vaccine did not undergo a temperature excursion. The patient did not experience any adverse reaction.
Pt c/o dry cough and SOB on Friday 3/24/06. Increase on 3/29/06, physician assistant at doctor's office.
allergic reaction; This is a spontaneous report from a contactable consumer. A 71-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration on 28Feb2021 (at a age of 71 year old) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On Mar2021 the patient experienced allergic reaction stated that between her first and second dose she had an allergic reaction to a different medication and was in the hospital. Last Friday (she said maybe it was the 25Mar2021) she went to get her second dose of the vaccine and they wouldn't give it to her, and she had to get confirmation from doctor that her reaction was not to the vaccine. Outcome of event was unknown.    Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021354364 similar report from same reporter